| Name | Encelimab |
|---|
| Description | Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |